September 7th, 2013
Visit-to-Visit Variability in Systolic BP Among Patients with Type 2 Diabetes
John Chalmers, MD phD and John Ryan, MD
John Chalmers and his coauthors discuss their analysis of data from the ADVANCE trial.
NEJM Journal Watch — Recent Cardiology Articles- Cardiovascular Outcomes of Tirzepatide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long Is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction